GPM6B
Neuronal membrane glycoprotein M6-b
Also known as: GPM6B_HUMAN, M6B, MGC17150, MGC54284
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13491
- Gene
- GPM6B
- Ensembl
- ENSG00000046653
- Chromosome
- X
- Canonical length
- 265 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a membrane glycoprotein that belongs to the proteolipid protein family. Proteolipid protein family members are expressed in most brain regions and are thought to be involved in cellular housekeeping functions such as membrane trafficking and cell-to-cell communication. This protein may also be involved in osteoblast differentiation. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are located on chromosomes Y and 22. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
265 residues, UniProt reviewed canonical sequence.
>Q13491|GPM6B
1 MKPAMETAAE ENTEQSQERK GCFECCIKCL GGVPYASLVA TILCFSGVAL FCGCGHVALA
61 GTVAILEQHF STNASDHALL SEVIQLMQYV IYGIASFFFL YGIILLAEGF YTTSAVKELH
121 GEFKTTACGR CISGMFVFLT YVLGVAWLGV FGFSAVPVFM FYNIWSTCEV IKSPQTNGTT
181 GVEQICVDIR QYGIIPWNAF PGKICGSALE NICNTNEFYM SYHLFIVACA GAGATVIALL
241 IYMMATTYNY AVLKFKSRED CCTKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPM6B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 710 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 710 nTPM
- cerebral cortex: 437 nTPM
- amygdala: 430 nTPM
- hippocampal formation: 389 nTPM
- midbrain: 365 nTPM
- basal ganglia: 349 nTPM
Single-cell type
- müller glia: 1,896 nCPM
- oligodendrocytes: 1,811 nCPM
- bergmann glia: 1,588 nCPM
- schwann cells: 1,459 nCPM
- astrocytes: 1,043 nCPM
- melanocytes: 877 nCPM
Immune cell
- plasmacytoid DC: 78 nTPM
- total PBMC: 0.7 nTPM
- myeloid DC: 0.3 nTPM
- basophil: 0.2 nTPM
- gdT-cell: 0.2 nTPM
- MAIT T-cell: 0.2 nTPM
Brain region
- white matter: 1,203 nTPM
- medulla oblongata: 927 nTPM
- cerebellum: 814 nTPM
- spinal cord: 798 nTPM
- basal ganglia: 746 nTPM
- hypothalamus: 663 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GPM6B.
Disease | ImmuneIEDB
Conditions an epitope on GPM6B was assayed in.
- glioblastoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.35
- gnomAD missense Z
- 1.99
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon development
- central nervous system myelination
- extracellular matrix assembly
- negative regulation of protein localization to cell surface
- negative regulation of serotonin uptake
- nervous system development
- ossification
- positive regulation of bone mineralization
- protein transport
- regulation of actin cytoskeleton organization
- regulation of focal adhesion assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPM6B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- SERT
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPM6B as an antibody target. Whether an autoantibody or antibody against GPM6B could matter depends on whether native GPM6B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPM6B is annotated at the cell surface, where native GPM6B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPM6B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...